![Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy - Chow - 2019 - American Journal of Hematology - Wiley Online Library Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy - Chow - 2019 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/b9844bfd-f3e5-4950-96c7-e033a661312d/ajh.25505.fp.png)
Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy - Chow - 2019 - American Journal of Hematology - Wiley Online Library
![Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia | Leukemia Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-018-0034-z/MediaObjects/41375_2018_34_Fig1_HTML.jpg)
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia | Leukemia
![Cancers | Free Full-Text | Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia Cancers | Free Full-Text | Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia](https://www.mdpi.com/cancers/cancers-13-03856/article_deploy/html/images/cancers-13-03856-g001.png)
Cancers | Free Full-Text | Impact of Immune Parameters and Immune Dysfunctions on the Prognosis of Patients with Chronic Lymphocytic Leukemia
![PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias](https://i1.rgstatic.net/publication/40045065_Tailoring_iron_chelation_by_iron_intake_and_serum_ferritin_The_prospective_EPIC_study_of_deferasirox_in_1744_patients_with_transfusion-dependent_anemias/links/0deec52099a9e36e42000000/largepreview.png)
PDF) Tailoring iron chelation by iron intake and serum ferritin: The prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias
Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged
![Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley](https://onlinelibrary.wiley.com/cms/asset/a3ab599c-f810-44a4-8d26-916b998a40ec/ajh.25584.fp.png)
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
![IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia](https://www.mdpi.com/ijms/ijms-18-02778/article_deploy/html/images/ijms-18-02778-g001.png)
IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
![Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/8fc6c8fc-4278-46f3-8889-44b9eb1ec507/fx1_lrg.jpg)
Evaluation of two in vitro assays for tumorigenicity assessment of CRISPR-Cas9 genome-edited cells: Molecular Therapy - Methods & Clinical Development
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease | Haematologica
![PDF) Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia PDF) Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia](https://i1.rgstatic.net/publication/322004418_Hypomorphic_FANCA_mutations_correlate_with_mild_mitochondrial_and_clinical_phenotype_in_Fanconi_anemia/links/5a65e9cc0f7e9b6b8fdcbbdb/largepreview.png)
PDF) Hypomorphic FANCA mutations correlate with mild mitochondrial and clinical phenotype in Fanconi anemia
![Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques: Molecular Therapy Prediction and validation of hematopoietic stem and progenitor cell off-target editing in transplanted rhesus macaques: Molecular Therapy](https://www.cell.com/cms/asset/bf4abce5-923c-432d-a36c-2aa49f87ae46/fx1.jpg)